Clinical Trial Update: Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial. [Phase 3]

View source ↗

Summary

Phase III trial evaluating amoxicillin-clavulanate alone or with ciprofloxacin in low-risk febrile neutropenia; study status withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Febrile Neutropenia | Phase 3 | Status: WITHDRAWN